Results 121 to 130 of about 35,244 (209)

Inhibition of SGLT2 reduces blood pressure in the early phase of salt‐sensitive hypertension in male Dahl‐SS rats independently of changes in renal inflammation

Physiological Reports, Volume 14, Issue 13, July 2026.
Abstract Salt‐sensitive hypertension is a progressive condition characterized by albuminuria, renal injury, and inflammation. The initiating mechanisms remain unclear. We hypothesized that early in salt‐sensitive hypertension, the proximal tubule is exposed to excess albumin, thereby triggering cytokine release and renal inflammation.
Rawan N. Almutlaq, Yotesawee Srisomboon, Sridhatri Guntipally, Andrew N. Hakeem, Amanda C. Veiga, Jaryd Ross, Babatunde S. Anidu, Alex Dayton, Scott M. O'Grady, Louise C. Evans   +9 more
wiley   +1 more source

Lipocalin 2 (LCN2) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Beyond Hemostasis: Platelet Biomarkers and Vascular‐Immune Crosstalk in Dengue

The FASEB Journal, Volume 40, Issue 12, 30 June 2026.
Several biomarkers are associated with platelet activation during dengue virus (DENV) infection. These include serum markers (AST, ALT, ferritin), platelet surface or secreted molecules (P‐selectin, PF4, RANTES, VEGF‐A, CD40L, TREM‐1, TLT‐1), immune and endothelial markers (TREM‐1, Ang‐1, Ang‐2), and viral components such as DENV EIII.
Amanda Beatriz Adriano da Silva‐Alencar, Amanda de Oliveira Matos, Daniel Francisco de Sousa, Jefferson do Carmo Dietz, Eugenio Damaceno Hottz, Marcelle Figueira Marques da Silva‐Sales, Helioswilton Sales‐Campos   +6 more
wiley   +1 more source

Glucocorticoid Receptor Translational Isoforms Generate Unique Glucocorticoid Responses in the Mouse Brain

The FASEB Journal, Volume 40, Issue 12, 30 June 2026.
GR‐A knockin mice were generated that express the classic full‐length glucocorticoid receptor (GR‐A) but lack the highly conserved translational isoforms GR‐B, GR‐C1, GR‐C2, GR‐C3, GR‐D1, GR‐D2, and GR‐D3 that have progressively shorter N‐terminal transactivation domains (NTDs).
Robert H. Oakley, Tatsuya Sueyoshi, Sivapriya Ramamoorthy, Viktoriya D. Nikolova, David R. Goulding, Jianying Li, Manas K. Ray, Sheryl S. Moy, John A. Cidlowski   +8 more
wiley   +1 more source

Lipocalin 2 [PDF]

, 2019
openaire   +1 more source

Striatal modulation by lipocalin-2

, 2018
Lipocalin-2 (LCN2) was first described as an acute-phase molecule involved in the innate immune response against several pathological stimuli. However, recent studies have also associated LCN2 as an important mediator in the central nervous system (CNS) physiology.
openaire   +1 more source

Emerging roles of lipocalin-2-mediated neuroimmune interactions in chronic pain and itch. [PDF]

Front Pharmacol
Sun S, Lin J, Wang X, Liu T, Zhou G, Kang P.   +5 more
europepmc   +1 more source

Lipocalin 2 orchestrates resistance to ferroptosis via AXL. [PDF]

Cell Rep
Wang SZ, Timken JP, Hong ES, Kaur S, Newby E, Kay KE, Mulkearns-Hubert EE, Silver DJ, Lee J, Rubin JB, Connor JR, Deleyrolle LP, Tiek D, Dhawan A, Lathia JD.   +14 more
europepmc   +1 more source

Lipocalin 2: a double-edged sword in cellular ferroptosis. [PDF]

Cell Biol Toxicol
Xia Z, Su X, Xie L, Zhang Z, He Y.
europepmc   +1 more source

Targeting lipocalin-2 for multiple sclerosis: a dual role in diagnosis and therapy. [PDF]

Front Immunol
Afridi R, Lee WH, Song M, Suk K.
europepmc   +1 more source